STATIN USE AND PROGNOSIS IN 12,865 NON‐HODGKIN LYMPHOMA PATIENTS TREATED IN THE RITUXIMAB‐ERA

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 35; no. S2; pp. 230 - 232
Main Authors Brånvall, E., Eloranta, S., Ekberg, S., Birmann, B.M., Smedby, K.E.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2017
Subjects
Immunotherapy
Lymphoma
Monoclonal antibodies
Non-Hodgkin's lymphoma
Patients
Prognosis
Rituximab
Targeted cancer therapy
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2438_94